This is a general term for any disease that affects the white matter of the brain. The white matter is like the wiring connecting different parts of the brain. Diseases affecting this area can cause a wide range of symptoms, depending on which part of the brain is affected.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Leukoencephalopathy is a broad term for diseases that damage the white matter of the brain and spinal cord. White matter is made of nerve fibers wrapped in myelin, a fatty insulating layer that lets signals travel quickly between nerve cells. When white matter is injured, those signals slow down or fail, which can affect movement, balance, coordination, speech, vision, thinking and behavior. Leukoencephalopathy is a description, not a single diagnosis. Some forms are inherited and are called leukodystrophies; others follow an infection, a toxic exposure or a medicine. The cause shapes almost everything that follows, including how fast symptoms change and what treatment can do, so finding it is the main goal of an evaluation. One inherited form, vanishing white matter disease (also called childhood ataxia with central nervous system hypomyelination or, in a severe early form, Cree leukoencephalopathy), is among the more common inherited white matter diseases, although it is still rare. It usually begins in early childhood with stiff muscles and unsteady movement, but milder forms can first appear in adolescence or adulthood, sometimes as changes in behavior or mood.
Causes fall into a few broad groups. Inherited forms come from changes in genes that build or maintain white matter. More than 50 leukodystrophies are known; they most often start in childhood, while others, such as CADASIL (an inherited disease of small blood vessels in the brain), more often appear in adults. Vanishing white matter disease is caused by changes in any of five genes (EIF2B1 through EIF2B5) that help cells adjust protein production under stress. It is inherited in an autosomal recessive pattern: a child is affected only when both parents pass on a changed copy, and parents who each carry one copy are usually healthy. People with this disease are unusually sensitive to physical stress. A fever, an infection, a minor head injury or a severe fright can bring on the first symptoms or cause a sudden setback. Not every leukoencephalopathy is inherited. Progressive multifocal leukoencephalopathy (PML) is a brain infection by the John Cunningham (JC) virus, a common virus that stays dormant in most people but can become active when the immune system is seriously weakened, as with advanced human immunodeficiency virus (HIV) infection, blood cancers, organ transplants or certain immune-suppressing medicines such as natalizumab (Tysabri). Toxic leukoencephalopathy can follow some chemotherapy, certain other medicines, heroin and other opioids, cocaine, inhaled solvents or other toxins.
Evaluation starts with a detailed history, including when symptoms began, whether skills are being lost, exposures, medicines, immune health and family history, followed by a neurological exam. Magnetic resonance imaging (MRI) of the brain is the key test. It shows where white matter is damaged and in what pattern, and some patterns point strongly toward a particular cause. When an inherited cause is suspected, genetic testing aims to identify the exact disease, often with gene panels or broader exome or genome sequencing. For vanishing white matter disease, expert guidance calls for genetic confirmation whenever the MRI suggests it, because other conditions can look similar on a scan. Blood, urine or spinal fluid tests can help identify other causes, including the JC virus in PML. Reaching a diagnosis can take time, and some people never receive a specific one. Once an inherited cause is found, genetic counseling helps families understand who else might be affected and what testing or family planning options exist.
Treatment depends on the cause. For most inherited forms there is no cure, and care focuses on symptoms and function: medicines for muscle stiffness and seizures; physical, occupational and speech therapy; and nutrition support, including a feeding tube when eating becomes unsafe or insufficient. A few inherited types have specific options. Cerebrotendinous xanthomatosis (CTX), a disorder of fat processing, can be slowed or stopped with chenodeoxycholic acid if it is found early, and stem cell or bone marrow transplant can help a small number of other types. For vanishing white matter disease, no treatment yet changes the underlying disease, although some are being studied in clinical trials. Preventing setbacks is therefore central. Expert recommendations include treating fever promptly with fever-reducing medicine, keeping up with routine vaccines (with fever control afterward), wearing a helmet for activities such as cycling and avoiding sports with a high risk of head injury. Some medicines and the stress of major surgery or anesthesia may also trigger decline, so any new prescription or planned procedure is best reviewed with the specialist team. Seizures are usually treated after a first episode, because they are linked to a harder course. In PML, there is no approved antiviral treatment. Restoring immune function, for example by starting HIV treatment or stopping natalizumab, is linked to better outcomes, which is why early recognition matters. In toxic leukoencephalopathy, care centers on stopping the exposure and supporting recovery.
The outlook varies widely with the cause. Most leukodystrophies worsen over time, though the pace differs from one type and one person to another. In general, symptoms that start at a younger age tend to progress faster. Vanishing white matter disease often follows an uneven path: periods of relative stability interrupted by sudden declines after fevers or injuries, with skills that may only partly return. It shortens life, and earlier onset usually means a more severe course. Daily life often includes rehabilitation, mobility aids, school or work support and careful planning around illness. Women and girls with the condition commonly develop reduced ovarian function, which can affect puberty, fertility and bone strength and is managed with an endocrinologist (a hormone specialist). Pregnancy needs close monitoring and delivery in a hospital with neurology and intensive care. PML is serious and is fatal for many people, though survival is better when immune function can be restored. Some people with toxic leukoencephalopathy recover partly or fully over months to years, while others do not. For families living with an inherited form, a specialist leukodystrophy center, care coordination, caregiver support and patient organizations can help as needs change. Some families also choose to join research registries or clinical trials.
Arrange an evaluation if a child or adult gradually loses skills such as walking, balance, speech, feeding, vision or hearing, or develops unexplained changes in coordination, thinking or behavior. If you have a weakened immune system, for example from HIV, a transplant or treatment with natalizumab or other immune-suppressing medicines, contact your care team the same day about new weakness, clumsiness, or speech, vision or thinking problems that build over days to weeks, as these can be early signs of PML. For someone with vanishing white matter disease, call the care team promptly about a fever, an infection or a knock to the head so treatment and monitoring can start early. Go to an emergency department if the person becomes much harder to wake, or suddenly loses the ability to walk, talk or swallow, as expert guidance supports hospital care for acute decline.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Leukoencephalopathy is like, what's helped you, or ask the community a question.